IXHL
NASDAQ · Pharmaceuticals
Incannex Healthcare Inc
$3.66
+0.02 (+0.55%)
Open$3.64
Previous Close$3.64
Day High$3.70
Day Low$3.50
52W High$20.31
52W Low$2.49
Volume—
Avg Volume110.0K
Market Cap43.55M
P/E Ratio—
EPS$-12.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 926.7K | 1.74M | 25.07M |
| Net Income | -505,122,035 | -854,851,131 | 4.81M |
| Profit Margin | -54,517.4% | -51,791.6% | 19.2% |
| EBITDA | -269,502,595 | -481,435,624 | 6.46M |
| Free Cash Flow | — | — | 4.01M |
| Rev Growth | -46.8% | -46.8% | +16.3% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |